219 related articles for article (PubMed ID: 33042140)
21. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells.
Reantragoon R; Corbett AJ; Sakala IG; Gherardin NA; Furness JB; Chen Z; Eckle SB; Uldrich AP; Birkinshaw RW; Patel O; Kostenko L; Meehan B; Kedzierska K; Liu L; Fairlie DP; Hansen TH; Godfrey DI; Rossjohn J; McCluskey J; Kjer-Nielsen L
J Exp Med; 2013 Oct; 210(11):2305-20. PubMed ID: 24101382
[TBL] [Abstract][Full Text] [Related]
22. TRAV1-2
Wong EB; Gold MC; Meermeier EW; Xulu BZ; Khuzwayo S; Sullivan ZA; Mahyari E; Rogers Z; Kløverpris H; Sharma PK; Worley AH; Lalloo U; Baijnath P; Ambaram A; Naidoo L; Suleman M; Madansein R; McLaren JE; Ladell K; Miners KL; Price DA; Behar SM; Nielsen M; Kasprowicz VO; Leslie A; Bishai WR; Ndung'u T; Lewinsohn DM
Commun Biol; 2019; 2():203. PubMed ID: 31231693
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Human Mucosal-associated Invariant T (MAIT) Cells.
Souter MNT; Loh L; Li S; Meehan BS; Gherardin NA; Godfrey DI; Rossjohn J; Fairlie DP; Kedzierska K; Pellicci DG; Chen Z; Kjer-Nielsen L; Corbett AJ; McCluskey J; Eckle SBG
Curr Protoc Immunol; 2019 Dec; 127(1):e90. PubMed ID: 31763790
[TBL] [Abstract][Full Text] [Related]
24. MR1-Restricted T Cells Are Unprecedented Cancer Fighters.
Vacchini A; Chancellor A; Spagnuolo J; Mori L; De Libero G
Front Immunol; 2020; 11():751. PubMed ID: 32411144
[TBL] [Abstract][Full Text] [Related]
25. Mucosal-Associated Invariant T Cells Develop an Innate-Like Transcriptomic Program in Anti-mycobacterial Responses.
Sharma M; Zhang S; Niu L; Lewinsohn DM; Zhang X; Huang S
Front Immunol; 2020; 11():1136. PubMed ID: 32582206
[TBL] [Abstract][Full Text] [Related]
26. T-cell receptor repertoire of human peripheral CD161hiTRAV1-2+ MAIT cells revealed by next generation sequencing and single cell analysis.
Held K; Beltrán E; Moser M; Hohlfeld R; Dornmair K
Hum Immunol; 2015 Sep; 76(9):607-14. PubMed ID: 26382249
[TBL] [Abstract][Full Text] [Related]
27. Atypical TRAV1-2
Awad W; Meermeier EW; Sandoval-Romero ML; Le Nours J; Worley AH; Null MD; Liu L; McCluskey J; Fairlie DP; Lewinsohn DM; Rossjohn J
J Biol Chem; 2020 Oct; 295(42):14445-14457. PubMed ID: 32817339
[TBL] [Abstract][Full Text] [Related]
28. Diverse MR1-restricted T cells in mice and humans.
Koay HF; Gherardin NA; Xu C; Seneviratna R; Zhao Z; Chen Z; Fairlie DP; McCluskey J; Pellicci DG; Uldrich AP; Godfrey DI
Nat Commun; 2019 May; 10(1):2243. PubMed ID: 31113973
[TBL] [Abstract][Full Text] [Related]
29. T-cell activation by transitory neo-antigens derived from distinct microbial pathways.
Corbett AJ; Eckle SB; Birkinshaw RW; Liu L; Patel O; Mahony J; Chen Z; Reantragoon R; Meehan B; Cao H; Williamson NA; Strugnell RA; Van Sinderen D; Mak JY; Fairlie DP; Kjer-Nielsen L; Rossjohn J; McCluskey J
Nature; 2014 May; 509(7500):361-5. PubMed ID: 24695216
[TBL] [Abstract][Full Text] [Related]
30. Human MAIT Cell Activation In Vitro.
Hagel JP; Garner LC; Bilton M; Mehta H; Leng T; Hackstein CP; Phalora P; Amini A; Akther HD; Provine NM; Edmans M; Willberg CB; Klenerman P
Methods Mol Biol; 2020; 2098():97-124. PubMed ID: 31792818
[TBL] [Abstract][Full Text] [Related]
31. MAIT cells and MR1-antigen recognition.
Keller AN; Corbett AJ; Wubben JM; McCluskey J; Rossjohn J
Curr Opin Immunol; 2017 Jun; 46():66-74. PubMed ID: 28494326
[TBL] [Abstract][Full Text] [Related]
32. The effects of 5-OP-RU stereochemistry on its stability and MAIT-MR1 axis.
Matsuoka T; Motozono C; Hattori A; Kakeya H; Yamasaki S; Oishi S; Ohno H; Inuki S
Chembiochem; 2021 Feb; 22(4):672-678. PubMed ID: 33034934
[TBL] [Abstract][Full Text] [Related]
33. MR1 displays the microbial metabolome driving selective MR1-restricted T cell receptor usage.
Harriff MJ; McMurtrey C; Froyd CA; Jin H; Cansler M; Null M; Worley A; Meermeier EW; Swarbrick G; Nilsen A; Lewinsohn DA; Hildebrand W; Adams EJ; Lewinsohn DM
Sci Immunol; 2018 Jul; 3(25):. PubMed ID: 30006464
[TBL] [Abstract][Full Text] [Related]
34. The Diverse Family of MR1-Restricted T Cells.
Gherardin NA; McCluskey J; Rossjohn J; Godfrey DI
J Immunol; 2018 Nov; 201(10):2862-2871. PubMed ID: 30397170
[TBL] [Abstract][Full Text] [Related]
35. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells.
Eckle SB; Birkinshaw RW; Kostenko L; Corbett AJ; McWilliam HE; Reantragoon R; Chen Z; Gherardin NA; Beddoe T; Liu L; Patel O; Meehan B; Fairlie DP; Villadangos JA; Godfrey DI; Kjer-Nielsen L; McCluskey J; Rossjohn J
J Exp Med; 2014 Jul; 211(8):1585-600. PubMed ID: 25049336
[TBL] [Abstract][Full Text] [Related]
36. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
[TBL] [Abstract][Full Text] [Related]
37. Altered composition and phenotype of mucosal-associated invariant T cells in early untreated rheumatoid arthritis.
Koppejan H; Jansen DTSL; Hameetman M; Thomas R; Toes REM; van Gaalen FA
Arthritis Res Ther; 2019 Jan; 21(1):3. PubMed ID: 30611306
[TBL] [Abstract][Full Text] [Related]
38. Understanding the Role of Mucosal-Associated Invariant T-Cells in Non-human Primate Models of HIV Infection.
Barber-Axthelm IM; Kent SJ; Juno JA
Front Immunol; 2020; 11():2038. PubMed ID: 33013862
[TBL] [Abstract][Full Text] [Related]
39. MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response.
Kawachi I; Maldonado J; Strader C; Gilfillan S
J Immunol; 2006 Feb; 176(3):1618-27. PubMed ID: 16424191
[TBL] [Abstract][Full Text] [Related]
40. Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease.
Juno JA; Waruk JLM; Wragg KM; Mesa C; Lopez C; Bueti J; Kent SJ; Ball TB; Kiazyk SA
Front Immunol; 2018; 9():1076. PubMed ID: 29868028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
